Buy ANY 5 Biomaterial Products, Receive 1 at No Cost! Use code B5G1Q125 Learn More
GEM 21S®, the first recombinant growth factor product for use in oral regenerative surgery. Learn More
CLINICAL CASE
1 – Clinical presentation at baseline, with the patient exhibiting multiple gingival recessions associated with dental hypersensitivity.2 – A coronally advanced flap was performed, with the interincisal papilla that was preserved. 3 – Xenogeneic cross-linked collagen matrix (Geistlich Fibro-Gide®).4 – Application of the collagen matrix over the recipient site.5 – Suturing of the collagen matrix to the de-epithelialized anatomical papillae using simple interrupted sutures (7/0 PGA).6 – Stabilization of the two collagen matrices.7 – The flap was coronally advanced and stabilized with sling sutures (7/0 polypropylene).8 – Clinical outcomes at 6 months showing complete root coverage of the frontal teeth, and a significant reduction on the first premolars. The patient reported a substantial reduction of the preoperative dental hypersensitivity, together with high treatment satisfaction.